Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Determining what age to move from stocks to bonds is vital for long-term financial health. Explore guidelines to help you plan your investment strategy.
23,118 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Monday brought a notable move for Circle Internet Group stock as rising demand for USDC underscored the crypto-stable...
When a major holder severs a stake in a big airline, it signals shifts in sentiment. We break down what cobalt capita...
A director just bought more than 11,000 Ardent Health shares, sparking questions about the stock after this insider m...
The Trade Desk surprised with strong earnings, yet its stock fell. This in-depth analysis breaks down the reasons beh...
A concentrated bet from a top consumer-focused fund puts Chime in the spotlight. Discover what the $227 million posit...
Insider trades by top executives can shape market perception. This guide explains what a chief medical officer sells ...
When a veteran value investor piles into a beaten-down name, traders take notice. Prem Watsa recently added to his Un...
When a quarterly miss hits the wires, investors scramble to interpret the fallout. This deep dive explains why calume...
Planet Labs stock popped today after a standout quarter and optimism about a path to profitability. This article brea...
A notable investor doubled down on XPLR Infrastructure after a sharp 42% rise, highlighting the appeal of long-term, ...
When a company's CFO unloads thousands of shares, investors naturally ask what it means. This analysis dives into amb...